Lumpyvax®

LUMPYVAX®

Reg. No. G3673 (Act 36/1947)

Namibia Reg. No. V06/24.4/184 [NS0]

INDICATIONS

For the prophylactic immunisation of cattle against lumpy skin disease.

COMPOSITION

Each 1 mℓ (1 dose) of the vaccine contains 10⁴ TCID₅₀ of freeze-dried, live, attenuated virus (SIS Neethling-type).

STORAGE

• Store between 2 °C and 8 °C. 
• Do not freeze.

WARNINGS

• Withdrawal period: Do not slaughter cattle for human consumption within 21 days of vaccination*.
• Vaccinate healthy animals only.
• A temporary decrease in milk production may occur.
• KEEP OUT OF REACH OF CHILDREN, UNINFORMED PERSONS AND ANIMALS.
• Although this vaccine has been extensively tested under a large variety of conditions, failure thereof may ensue for a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.

SPECIAL WARNINGS AND PRECAUTIONS FOR USE

• Vaccinated cows that develop an antibody response will confer maternal immunity to lumpy skin disease by means of colostrum and this last for 4 to 6 months.

Maternal antibodies in calves may have an influence on the vaccine efficacy.

• Only healthy animals should be vaccinated.

ADVERSE REACTIONS

• A temporary decrease in milk production may occur in very rare cases.
• In regions in which Lumpy skin disease is not endemic, small lumps, sometimes accompanied by fever, may occur in very rare cases. These lumps usually resolve without treatment.
• Injection site swelling may occur in very rare cases.

PRECAUTIONS

• Sterilise all equipment before use, by boiling in water for at least 15 minutes. Do not use disinfectants or methylated spirits for sterilising.
• Ensure that all equipment is kept clean and sterile during vaccination.
• Keep the vaccine cool and avoid exposure to direct sunlight and high temperatures during inoculation.
• Destroy any unused vaccine as well as all empty vaccine containers and all vaccination equipment according to local disposal regulations after vaccination.
• Do not store partially used containers for future use and use the entire contents when opened.
• It is good vaccination practice, when handling the vaccine, to avoid contact with the eyes, hands and clothing.

DIRECTIONS FOR USE – USE ONLY AS DIRECTED

Use a sterile syringe to transfer approximately 5 mℓ of sterile diluent to the bottle containing the freeze-dried vaccine.

Mix until all the powder is dissolved and then transfer this suspension back to the remaining sterile diluent and again mix well using the sterile syringe.

Shake the bottle before filling the syringe.

DOSAGE

Inject 1 mℓ per animal subcutaneously.

RECOMMENDATIONS FOR USE

• If possible, all animals should be vaccinated during spring.
• Calves from vaccinated cows should be vaccinated at 6 months of age.
• Calves from unvaccinated cows may be vaccinated at any age.
• Pregnant cows may be vaccinated with Lumpyvax^®.
• A booster vaccination should be given annually.
• Immunity starts to develop about 10 days after immunisation and animals should be fully protected after 3 weeks. (The vaccine may not necessarily confer absolute immunity to all animals.)
• A small percentage of cattle are naturally immune to lumpy skin disease virus and do not develop antibodies following vaccination. When this occurs, there is no colostrum antibody protection, and the calves of these cows may be at risk from an early age.

PRESENTATION

Vials containing 20 mℓ (20 doses) and 100 mℓ (100 doses).

REGISTRATION HOLDER

Intervet South Africa (Pty) Ltd.

20 Spartan Road, Spartan

1619, RSA

Tel: +27 (0) 11 923 9300

Email: masdahza@msd.com

www.msd-animal-health.co.za

DATE OF PUBLICATION OF PACKAGE INSERT

28 September 2017